NorthWest Biotherapeutics Inc (NWBO)

[iclight]

Try reading my whole post and responding the specifics.

The sickest of the total GBM population, which you people keep quoting in the 5% 5 year survival includes all those who failed the inclusion/exclusion criteria.

A patient with biopsy only and not near total GTR is sicker than the patient with total or near total GTR. And they weren't included in the trial. This trial limited participants to under 70 years of age. 25% of GBM patients are diagnosed over 70. You see those "disease progression", "general in/exclusion/history criteria", "clinical deterioration", and "surgery not done or processed" exclusions? Those people are sicker than the ones who made the trial.



Since you don't understand basic inclusion/exclusion criteria at this point in your financial gamble there is no point in arguing with you. Hell, where is all the control arm data? They won't release it.

Where is the comparison of ALL mesenchymal patients in the trial comparing the trial control arm to the trial treatment arm?